Sinomenine, an isoquinoline alkaloid which ameliorates colitis and inflammatory gene expression in several mouse models of IBD [64, 65], also reduces the levels of cAMP, intracellular Ca2+, and phosphorylated CREB in morphine-treated SH-SY5Y cells [66]. This evidence concerns the gene CREB1 and inflammatory bowel disease.